This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
10 - 12 June, 2025
Congress CenterBasel Switzerland

Scientific Program Partner

Meeting agenda created in conjunction with The Antibody Society.

10 - 12 June, 2025|Congress Center, Basel Switzerland

Where antibody and protein innovation is driven to commercial success

Europe's leading antibody event for discovery, engineering and therapeutic development in Neurodegeneration, Metabolism, Autoimmunity & much more.

Antibody Engineering Europe...The Numbers

+

Attendees

+

Speakers

+

Sponsors & Exhibitors

+

Poster Presentations

Advance Your Antibody Discovery Through Insights, Innovation, and Networking at Antibody Engineering & Therapeutics Europe

Revolutionise Antibody Discovery with Cutting-Edge Insights

Our expertly curated scientific agenda advances your antibody discovery and engineering initiatives. With 9 focused session themes featuring case studies and interactive discussions, uncover strategies to enhance discovery timelines and engineering precision.

Poster Presentations to Showcase your Research

Gain recognition for your research by presenting a poster at the event. Showcase your findings, engage with leading experts, and expand your network to elevate your profile in the global community.

Who Will You Meet?

Connect with more than 350 leaders in antibody and protein engineering, including renowned industry and academic scientists, as well as therapeutic development experts, who will share the latest preclinical and clinical data on antibodies, ADCs, bispecifics, and immuno-oncology programs.

Find Your Next Partner in Antibody Discovery and Engineering

Our Exhibit Hall features over 30 partners showcasing the latest advancements in the antibody field. Explore innovative technologies and solutions to enhance research and accelerate the discovery process for commercial success.

Taking Center Stage in Charming Basel

This year, the heart of antibody research shifts to Basel, a city where world-class science meets vibrant culture. Nestled on the Rhine, Basel’s stunning architecture, renowned museums, and lively café scene provide the perfect backdrop for inspiration, connection, and collaboration.

Enhance Your Event Experience with the ConnectMe

Our industry-leading ConnectMe app enhances your onsite experience with real-time updates and meeting scheduling. Access the attendee list, personalise your agenda, and engage with digital posters for seamless networking!

Next-Gen Antibody Discoveries: 9 Topic Streams to Drive Innovation and Maximise Efficacy

Level up your antibody expertise at Antibody Engineering & Therapeutics Europe 2025. Your ticket includes access to all conference sessions, interactive discussions, and networking opportunities, plus 12 months of on-demand recordings to enhance your learning.

Emerging In Vitro Approaches to Antibody Discovery

  • Accelerate Antibody Discovery Timelines
  • Harness Cutting-Edge Screening Technologies
  • Address Challenges in Target Validation
  • Optimise Lead Selection and Development

Advanced In Vivo Antibody Discovery

  • Unlock Novel Therapeutic Targets
  • Leverage State-of-the-Art Animal Models
  • Overcome Developmental Bottlenecks
  • Enhance Predictability and Translational Success

Enhanced Therapeutic Function Through Fc Engineering

  • Amplify Immune Effector Functions
  • Optimise Pharmacokinetics and Stability
  • Overcome Resistance Mechanisms
  • Drive Next-Generation Antibody Therapies

Multi-specific Engineering

  • Expand Therapeutic Efficacy Across Multiple Targets
  • Enhance Binding Affinity and Specificity
  • Facilitate Combination Therapies and Synergistic Effects
  • Address Complex Diseases with Innovative Solutions

Agonist Antibodies, Co-stimulation & Combination Therapy

  • Maximise Immune Activation Through Agonist Antibodies
  • Enhance Therapeutic Outcomes with Co-stimulation Strategies
  • Facilitate Effective Combination Therapies for Improved Efficacy
  • Target Complex Diseases with Innovative Therapeutic Approaches

Beyond IgG: Next-gen Therapeutic Scaffolds & Antibody Formats

  • Explore Innovative Therapeutic Scaffolds Beyond Traditional IgG
  • Enhance Targeting and Specificity with Novel Antibody Formats
  • Improve Pharmacokinetics and Safety Profiles of New Biologics
  • Address Limitations of Conventional Antibodies in Therapeutic Applications

Therapeutic Antibody Applications Beyond Oncology

  • Target Pathological Mechanisms in Neurodegenerative Diseases
  • Develop Therapeutics for Metabolic Disorders with Precision
  • Leverage Antibody Engineering to Cross the Blood-Brain Barrier
  • Explore Novel Approaches for Diagnosis and Treatment

Antibodies for Autoimmune Disease

  • Target Autoantigens to Modulate Immune Responses
  • Develop Biologics for Precision Treatment of Autoimmune Conditions
  • Enhance Efficacy and Safety with Novel Antibody Formats
  • Explore Mechanisms of Tolerance and Disease Reversal

Innovations with Antibody Payloads

  • Harness Targeted Delivery for Enhanced Therapeutic Efficacy
  • Utilize Antibody-Drug Conjugates to Overcome Resistance
  • Develop Innovative Protein Degraders for Disease Modulation
  • Explore Synergistic Effects of Conjugates and Degradation Strategies

About The Antibody Society

The Antibody Society is an international, non-profit trade association serving individuals and organizations involved in antibody-related research and development. We research and analyze data on targeted therapeutics developed by the biopharmaceutical industry, and distribute our results and commentary via the Society’s website, presentations and publications. The Society hosts educational webinars and Symposia, and serves as the home for the Adaptive Immune Receptor Repertoire (AIRR) Community, which focuses on the generation, use, sharing and standardization of next-generation sequencing of antibodies and T cell receptors. In addition, we engage with international agencies on matters of importance to the antibody community.

Our members serve as the Scientific Advisors for the Antibody Engineering & Therapeutics conferences. The scientific programs for the meetings are designed by our Meetings Committee.

To learn more about The Antibody Society, meeting advisors and guest chairs please click here.

Connecting with Key Antibody Decision Makers

Put yourself in front of key decision makers within the antibody engineering landscape at Antibody Engineering & Therapeutics Europe.
We provide flexible, tailored solutions to optimize your investment. Below are some examples of how you can get involved at the event. There's no better place to network with core audiences and make lasting connections.

To learn more about available opportunities or to begin building your custom sponsorship package, please contact:

Blake Shuka: BShuka@informaconnectls.com